Congratulations to Emily Levitt, who is this year’s recipient of the Darlene Walton Scholarship Award! This award recognizes students who demonstrate excellence in mental health and addiction research, doing work that enhances practice.
Read More
Infographic: new findings from study exploring long-term recovery from addiction
HRI has released a new infographic featuring recent findings from a study shedding light on the process of recovery from mental illness and addiction.
Read More
HRI awarded $100K from CCSA, Health Canada to explore impacts of cannabis legalization
HRI is the proud recipient of $100,000 in funding from the Canadian Centre on Substance Use and Addiction (CCSA) and Health Canada to study the effects of cannabis legalization on at-risk populations, including people requiring treatment for mental illness and substance use disorder (SUD).
Read More
New findings focus on screening tools that can improve addiction treatment and planning
In our latest Research Snapshot, we profile findings about improvements to screening tools that may help to identify concurrent mental health conditions in people requiring treatment for addiction.
Read More
New funding will support research exploring impact of COVID-19 on mental health
HRI Senior Scientist, Dr. James MacKillop, has received $491,000 from the Canadian Institutes of Health Research (CIHR) for a study that will examine the impact of COVID-19 on mental health and substance use.
Read MoreInternational study explores how AA contributes to recovery
Treatment of alcohol use disorder is multi-faceted and often includes participation in mutual-support groups, the oldest and largest of which is Alcoholics Anonymous (AA). Although frequent AA meeting attendance is associated with greater abstinence from alcohol, there is little understanding of the specific mechanisms by which AA benefits people. In other words, we know that AA works, […]
Read MoreExploring the use of CBD in treating alcohol use disorder
The CBD industry is booming. CBD (short for cannabidiol) is a chemical compound derived from the cannabis plant that is marketed as a cure-all and added to everything from bath bombs to dog treats. But has the hype of CBD gotten ahead of the science?
Read MoreHRI Senior Scientist contributes to national discussions on the legalization of cannabis
As Canada enters its second month following the nationwide legalization of cannabis, Dr. James MacKillop, HRI Senior Scientist and Director of the Peter Boris Centre for Addictions Research and the Michael G. DeGroote Centre for Medicinal Cannabis Research, is encouraging Canadians to think critically about cannabis use.
Read MoreAdvancing research for military and veteran mental health
Military members and veterans are among those most vulnerable to post-traumatic stress disorder (PTSD). There is an urgent need to identify new and innovative treatments that will help military members suffering from trauma-related illnesses.
Read MoreUpcoming symposium on addiction and PTSD
Addiction and post-traumatic stress disorder (PTSD) often occur together, causing debilitating consequences for those affected. There is little consensus among clinicians about how best to treat individuals suffering from both disorders, but new research is providing hope for patients and healthcare providers alike. This will be the focus of an upcoming symposium.
Read More